This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Case Western Reserve University. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: The Innovations of Songqi Gao
Introduction
Songqi Gao is a notable inventor based in Beachwood, OH (US). He has made significant contributions to the field of therapeutic compositions, particularly through his innovative work involving polysaccharide conjugates. With a total of 3 patents, Gao's inventions are paving the way for advancements in medical treatments.
Latest Patents
Gao's latest patents focus on polysaccharide therapeutic conjugates. One of his key inventions is a composition that includes a polysaccharide linked to at least one retinoid through a covalent linkage to a monosaccharide subunit of the polysaccharide. This innovative linkage is designed to be degradable by hydrolysis during digestion, allowing for controlled, delayed, and sustained delivery of the retinoid upon enteral administration to a subject. This technology has the potential to enhance the effectiveness of retinoid therapies.
Career Highlights
Songqi Gao is affiliated with Case Western Reserve University, where he continues to engage in groundbreaking research. His work is characterized by a commitment to developing novel therapeutic solutions that can improve patient outcomes. Gao's expertise in polysaccharide chemistry and therapeutic applications has positioned him as a valuable contributor to the scientific community.
Collaborations
Gao collaborates with esteemed colleagues such as Krzysztof Palczewski and Zheng-Rong Lu. These partnerships enhance the research environment and foster innovation in their respective fields.
Conclusion
In summary, Songqi Gao is an accomplished inventor whose work on polysaccharide therapeutic conjugates is making a significant impact in the medical field. His contributions are essential for the development of advanced therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
